{"id":44447,"date":"2026-03-20T10:43:08","date_gmt":"2026-03-20T10:43:08","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/44447\/"},"modified":"2026-03-20T10:43:08","modified_gmt":"2026-03-20T10:43:08","slug":"novo-nordisks-patent-expires-indian-pharma-lines-up-for-ozempic-like-weight-loss-drugs-outlook-business","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/44447\/","title":{"rendered":"Novo Nordisk&#8217;s Patent Expires, Indian Pharma Lines Up for Ozempic-Like Weight-Loss Drugs \u2013 Outlook Business"},"content":{"rendered":"<p>Other companies, including Divi\u2019s Laboratories, Dr. Reddy\u2019s Laboratories, Cipla Limited, Sun Pharmaceutical Industries, Zydus Lifesciences, Torrent Pharmaceuticals, and Wockhardt, saw gains of 1\u20132%. The rally pushed the Nifty Pharma index up by nearly 2%, making it one of the top-performing sectoral indices on the National Stock Exchange of India.<\/p>\n","protected":false},"excerpt":{"rendered":"Other companies, including Divi\u2019s Laboratories, Dr. Reddy\u2019s Laboratories, Cipla Limited, Sun Pharmaceutical Industries, Zydus Lifesciences, Torrent Pharmaceuticals, and&hellip;\n","protected":false},"author":2,"featured_media":44448,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[271],"tags":[22125,3335,25220,25222,25221,25226,272,3102,23396,25225,25224,689,25223,1910,280],"class_list":["post-44447","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novo-nordisk","tag-generic-drugs","tag-glp-1","tag-indian-pharma","tag-market-competition","tag-natco-pharma","tag-nifty-pharma","tag-novo-nordisk","tag-ozempic","tag-patent-expiry","tag-pharma-stocks","tag-price-correction","tag-semaglutide","tag-sun-pharma","tag-wegovy","tag-weight-loss"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@dk\/116261093654705534","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/44447","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=44447"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/44447\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/44448"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=44447"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=44447"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=44447"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}